U.S. Beverage Stock News

NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Assessing Amicus Therapeutics (FOLD) After Strong One Year Share Price Performance

If you are wondering whether Amicus Therapeutics at around US$14.37 is attractively priced or already reflecting a lot of optimism, you are in the right place to focus on what the numbers are actually saying about value. The stock's return profile, with 0.3% over the last 7 days, 0.5% over 30 days, 0.7% year to date and 61.6% over 1 year, suggests the market has been reassessing the company over different time frames. Recent news around Amicus Therapeutics has continued to center on its role...
NasdaqGS:CNTA
NasdaqGS:CNTABiotechs

Why Centessa Pharmaceuticals (CNTA) Is Up 5.7% After Advancing ORX750 Toward Registrational Sleep-Disorder Trials

Centessa Pharmaceuticals recently reported past Phase II progress for its orexin agonist ORX750 in narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia, highlighting clinically meaningful effects alongside a favorable safety and tolerability profile. The company also outlined plans for registrational studies in rare hypersomnias, expanded its open-label extension to four weeks, and began preparing for regulatory engagement and commercial build-out, underscoring how central ORX750...
NasdaqGS:NTSK
NasdaqGS:NTSKSoftware

Netskope (NTSK) Is Up 14.5% After Launching AI Security Suite And Issuing 2027 Guidance

Netskope, Inc. has reported its fourth-quarter 2026 results, with sales of US$196.33 million and a net loss of US$56.77 million, and unveiled guidance for fiscal 2027 alongside the launch of its Netskope One AI Security suite. The introduction of Netskope One AI Security, which combines agentic AI protection, guardrails, gateways, and red teaming in a unified platform, positions the company directly in the emerging market for securing generative and enterprise AI use. We’ll now examine how...
NasdaqGS:CPB
NasdaqGS:CPBFood

Campbell Soup (CPB) Q2 EPS Steady At US$0.65 Tests Bullish Margin Improvement Narrative

Campbell's (CPB) has just reported its latest results with Q2 2026 revenue of US$2.68 billion and basic EPS of US$0.65, setting the tone for how the rest of the year may shape up. Looking back over recent quarters, revenue has moved between US$2.29 billion in Q4 2024 and US$2.77 billion in Q1 2025, while basic EPS has ranged from a small loss of US$0.01 in Q4 2024 to US$0.73 in Q1 2025. This gives investors a clear view of how sales and earnings have tracked into this quarter. With net income...
NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

A Look At AIRO Group Holdings (AIRO) Valuation As It Prepares For Cantor 2026 Conference Presentation

Conference spotlight and why AIRO is on more investor radars AIRO Group Holdings (AIRO) is set to present at the 2026 Cantor Global Technology & Industrial Growth Conference on March 11 in New York, giving investors a closer look at its aerospace and defense business. With Co Founder and Executive Chairman Chirinjeev Baboo Kathuria, Chief Executive Officer Joe Burns and Chief Financial Officer Mariya Pylypiv on stage, the session could offer more detail on AIRO’s drone, avionics, training and...
NYSE:UTZ
NYSE:UTZFood

Utz Brands Debuts Protein Snacks As Share Price Trails Analyst Valuation

Utz Brands (NYSE:UTZ) presented new protein-enriched snacks and globally inspired flavors at Natural Products Expo West. The lineup includes Boulder Canyon Agave Sriracha kettle chips and a high protein snack range with gluten free, non GMO, and kosher options. The launch targets growing interest in snacks that combine higher protein content with bolder, globally influenced taste profiles. For investors watching NYSE:UTZ, the new products come at a time when the share price is around $7.52,...
NYSE:MOS
NYSE:MOSChemicals

Mosaic Turns Fertilizer Byproduct Into Rare Earths Opportunity In Brazil

Mosaic (NYSE:MOS) has entered a joint agreement with Rainbow Rare Earths to advance the Uberaba rare earths project in Brazil. The partners plan to process phosphogypsum, a fertilizer byproduct, to produce rare earths such as neodymium and praseodymium. The initiative expands Mosaic’s business focus beyond fertilizers into materials used in clean energy and high tech applications. Mosaic, trading at $29.15, is better known for its fertilizers, so this rare earths move gives investors a...
NYSE:VVV
NYSE:VVVSpecialty Retail

Valvoline Blends Community Giving And Finance Shakeup In Evolving Investor Story

Valvoline (NYSE:VVV) has launched the Happy to Help Fund in partnership with Blue Grass Community Foundation to back mental and physical well-being projects for children and youth in Lexington. The company has named Jordan M. Denny as Chief Accounting Officer and Controller, marking a key update to its executive leadership team. For you as an investor, this pairs a fresh community initiative with a leadership change at a company best known for vehicle lubricants, services, and related...
NasdaqCM:IMUX
NasdaqCM:IMUXBiotechs

A Look At Immunic (IMUX) Valuation As Reverse Split Proposal And Conference Appearance Draw Attention

Immunic (IMUX) is back on investors’ radar after proposing a reverse stock split ahead of an April 14 special shareholder meeting, while management prepares to speak at the Leerink Global Healthcare Conference on March 11. See our latest analysis for Immunic. Those recent corporate updates have come alongside sharp share price moves, with a 1 day share price return of 12.4% and a 30 day share price return of 103.08% contributing to a year to date share price return of 148.71%. However, the 5...
NasdaqGM:VNDA
NasdaqGM:VNDABiotechs

Vanda Pharmaceuticals (VNDA) Is Up 13.3% After Rare FDA Hearing Granted on HETLIOZ Jet Lag Bid

Vanda Pharmaceuticals recently received a decision from the U.S. FDA granting a rare formal evidentiary public hearing to review the agency’s proposed refusal to approve a supplemental new drug application for HETLIOZ (tasimelteon) as a treatment for jet lag disorder. This hearing, which follows Vanda’s earlier legal win requiring the FDA to more fully address its clinical evidence, highlights unusually high regulatory and scientific scrutiny around expanding HETLIOZ into a large, currently...
NasdaqCM:CODA
NasdaqCM:CODAElectronic

Assessing Coda Octopus Group’s Valuation After A New 52 Week High And Rising Operating Profit

New 52-week high puts recent gains in focus Coda Octopus Group (CODA) has hit a new 52-week high, coinciding with higher operating profit and a firm market position, drawing more investor attention to how the stock’s recent strength lines up with its fundamentals. See our latest analysis for Coda Octopus Group. The share price has slipped back 12.8% over the last day to US$14.62, but that comes after a strong run, with a 90-day share price return of 62.4% and a 1-year total shareholder return...
NYSE:TREX
NYSE:TREXBuilding

Trex Refuge Fire Resistant Decking Launch Meets Depressed Valuation Expectations

Trex Company (NYSE:TREX) has launched Trex Refuge, a fire-resistant decking line designed for high fire-risk regions. The product is engineered to meet Class A Flame Spread and ignition resistance standards for Wildland-Urban Interface zones. Trex Refuge comes with a 50-year residential warranty and targets homeowners and builders in fire-prone communities. Trex is rolling out Trex Refuge at a time when its shares trade at $38.16 and its 1 year return stands at a 30.6% decline. Over 5...
NYSE:AXTA
NYSE:AXTAChemicals

Axalta Selloff Deepens After Q4 Miss And Softer 2026 Outlook

Axalta Coating Systems (NYSE:AXTA) reported a weak Q4 2025, with both earnings and revenue coming in below expectations. The company guided for a soft Q1 2026 and warned of a mid single digit revenue decline. This outlook has been followed by sustained share price pressure and heavier institutional selling. For investors watching NYSE:AXTA, the new guidance has quickly fed into market pricing. The stock closed at $28.35 and is down 9.7% over the past week and 17.1% over the past month, with...
NasdaqGS:MRTN
NasdaqGS:MRTNTransportation

Marten Transport Verdict Puts $20 Million Legal And Valuation Risks In Focus

Webb County jurors found Marten Transport liable for a truck crash caused by an illegal maneuver by one of its drivers. The jury awarded a record $20,000,000 verdict to the injured plaintiff, highlighting operational and safety concerns. The decision raises legal and reputational questions for Marten Transport that could be relevant for current and potential shareholders. At a current share price of $12.08, Marten Transport (ticker NasdaqGS:MRTN) is coming under fresh scrutiny as investors...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

Assessing Allot (ALLT) Valuation As Investor Focus Builds Around Upcoming Cantor Conference Presentation

Allot (NasdaqGS:ALLT) is set to present at the 2026 Cantor Global Technology & Industrial Growth Conference in New York on March 11, where CEO and President Eyal David Harari will brief investors. See our latest analysis for Allot. Against this backdrop, Allot’s recent share price performance has been weak, with a 30 day share price return of 34.34% and a year to date share price return of 29.92%. At the same time, the 3 year total shareholder return sits at 165.49%, suggesting longer term...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

AeroVironment (AVAV) Q3 Loss Of US$156.6 Million Tests Bullish Margin Narratives

AeroVironment (AVAV) just posted Q3 2026 results with revenue of US$408.0 million and a basic EPS loss of US$3.15, alongside trailing twelve month revenue of about US$1.6 billion and a TTM EPS loss of US$5.15. Over recent quarters, revenue has moved from US$167.6 million in Q3 2025 to US$275.1 million in Q4 2025, then US$454.7 million in Q1 2026, US$472.5 million in Q2 2026 and now US$408.0 million in Q3 2026. Quarterly basic EPS has swung between a profit of US$0.59 and losses ranging from...
NasdaqGS:IDCC
NasdaqGS:IDCCSoftware

InterDigital Insider Selling Trend Raises Questions On Valuation And Outlook

InterDigital's Chief Technology Officer has sold company shares, continuing a year-long pattern of insider selling. No insider share purchases at InterDigital, NasdaqGS:IDCC, have been reported over the same period. This activity adds a fresh data point for investors tracking internal sentiment and executive behavior at the company. InterDigital, NasdaqGS:IDCC, focuses on wireless and video technology research, licensing its intellectual property to device makers and network operators. In a...
NYSE:WTI
NYSE:WTIOil and Gas

Assessing W&T Offshore (WTI) Valuation After 2025 Earnings Reveal Lower Revenue And Wider Net Loss

Earnings snapshot and dividend update W&T Offshore (WTI) has drawn fresh attention after reporting fourth quarter and full year 2025 results, with lower annual revenue, a larger net loss, and a maintained quarterly dividend. See our latest analysis for W&T Offshore. The latest earnings release and the recent affirmation of the US$0.01 quarterly dividend came alongside a 67.65% 3 month share price return and a 94.69% 1 year total shareholder return. However, the 3 year total shareholder return...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

Is Cogent Communications (CCOI) Now Attractively Priced After A 67.4% One Year Share Price Slump

Wondering if Cogent Communications Holdings is now priced attractively or if the share price still does not reflect its fundamentals? This article walks through the key valuation angles to help you frame that question for yourself. The stock closed at US$21.34, with returns of a 7.6% decline over 7 days, a 14.9% decline over 30 days, a 3.5% gain year to date, and a 67.4% decline over 1 year, which naturally raises questions about how the market is reassessing its prospects and risks. Recent...
NasdaqGS:OTEX
NasdaqGS:OTEXSoftware

Is It Time To Reconsider Open Text (OTEX) After Prolonged Share Price Weakness

If you are wondering whether Open Text's share price still reflects its underlying business, you are not alone. This article looks at what the numbers say about value rather than headlines. At a last close of US$23.99, the stock has seen returns of a 4.3% decline over 7 days, a 5.4% decline over 30 days, a 24.4% decline year to date and a 1.6% decline over the past year, with a 25.5% decline over 3 years and a 43.3% decline over 5 years. Recent trading has been shaped by ongoing investor...
NYSE:GNRC
NYSE:GNRCElectrical

Generac Design Awards Highlight Broader Home Energy And Backup Power Ambitions

Generac Holdings (NYSE:GNRC) received multiple GOOD DESIGN Awards for products in home standby, portable generators, and energy storage systems. The recognition covers several product lines that focus on design, usability, and sustainability. The awards highlight Generac’s efforts to differentiate within the broader energy technology and backup power market. For you as an investor, this recognition ties directly to how Generac positions itself across backup power and energy management. The...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

Trump Media Bitcoin Pivot Raises Questions On Valuation And Execution Risks

Trump Media & Technology Group (NasdaqGM:DJT) has outlined a pivot toward Bitcoin treasury management as a primary business activity. The company plans to expand its financial assets, introduce bitcoin linked options, and pursue new ventures tied to ETFs and prediction markets. Management has also flagged initiatives in AI powered search and a potential merger related to fusion energy as part of a broader shift beyond the Truth Social platform. For investors following Trump Media &...
NYSE:MTN
NYSE:MTNHospitality

Reassessing Vail Resorts (MTN) After A Five Year Slide And DCF Upside Potential

If you are wondering whether Vail Resorts is attractively priced after a long slide in the share price, this article walks through what the current valuation might be telling you. The stock last closed at US$138.53, with returns of 1.6% over 7 days, a 1.8% decline over 30 days, a 3.4% gain year to date, and declines of 9.2%, 26.2% and 47.5% over the past 1, 3 and 5 years respectively. Recent news coverage has focused on Vail Resorts as a large operator in the ski and mountain resort space,...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Is It Time To Reassess Nuvalent (NUVL) After Recent Trial And Pipeline Updates

If you are wondering whether Nuvalent at around US$100 a share still offers fair value, you are not alone. This article is built to help you make sense of the current price tag. The stock is roughly flat year to date with a 0.8% decline, but over the last year it has returned 38.0%, and over three years the return is very large. That performance can change how investors think about both upside and risk. Recent headlines around Nuvalent have focused on its progress as a clinical stage...